Global markets for RNAi drug & technologies to reach $24.1 billion by 2015

The global RNA interference (RNAi) drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015 at a 5-year compound annual growth rate (CAGR) of 27.9%.

Learn about the latest trends in RNAi therapeutics, with focus on the main areas of clinical need, general/proprietary technologies and company pipelines, and the activities and strategies of RNAi-based developers. This report also provides forecasts for market growth to 2015 across major RNAi market segments...

Use this report to:

• Learn about emerging RNAi molecules and delivery technologies as well as new molecular targets and pipeline drugs
• Assess important trends in technology development for RNAi in major therapeutic areas and licensing opportunities for novel delivery platforms
• Evaluate the commercial potential of emerging therapeutics and delivery technologies based on crucial statistics and analysis of the market structure, market size, and key drug segments
• Incorporate analysis of competitors and collaborators in developing RNAi technologies, the market shares of key players and drugs, and the latest RNAi-related patenting trends into your business strategy.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

  RSS Feeds – Biotechnology

SUMMARY FIGURE

GLOBAL MARKET FOR RNAI DRUG DELIVERY TECHNOLOGIES, 2009-2015

($ MILLIONS)

Source: BCC Research

Markets for immunoagents, probes and molecular diagnostics to grow to $60.3 billion by 2016

The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.

Learn about the major research and development (R&D) initiatives which are leading to the development of new products to improvements in the sensitivities and performance of existing immunoassay products. Company profiles are also included...

Use this report to:

• Gain a detailed analysis of the consumption and future growth potential of immunoagents, gene probes, and molecular diagnostics
• Determine recent technological developments, future industry trends, and emerging business opportunities
• Analyze the underlying influences brought about by rapid developments in diagnostic products, changes in governmental regulations, and the evolving economies of countries such as China, India, the Pacific Rim, Australia, Brazil, Russia, and the Middle East
• Outline the international supply and demand for compounds used in immunoassays and in probes, including gene probes and related chemicals employed in diagnostic tests.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
MARKETS FOR IMMUNOAGENTS, PROBES AND MOLECULAR DIAGNOSTICS, 2009-2016
($ MILLIONS)

Source: BCC Research